摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-methyl-piperazin-1-yl)-1H-benzoimidazole-2-sulfonic acid | 1025713-33-0

中文名称
——
中文别名
——
英文名称
5-(4-methyl-piperazin-1-yl)-1H-benzoimidazole-2-sulfonic acid
英文别名
6-(4-methylpiperazin-1-yl)-1H-benzimidazole-2-sulfonic acid
5-(4-methyl-piperazin-1-yl)-1H-benzoimidazole-2-sulfonic acid化学式
CAS
1025713-33-0
化学式
C12H16N4O3S
mdl
——
分子量
296.35
InChiKey
YGSXGZJIRUGOBR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.8
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    97.9
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Novel compounds useful for the treatment of degenerative & inflamatory diseases
    申请人:Edward Paul John
    公开号:US20090137549A1
    公开(公告)日:2009-05-28
    The present invention relates to compounds that are inhibitors of PDE1A, a phosphodiesterase that is involved in the modulation of the degradation of cartilage, joint degeneration and diseases involving such degradation and/or inflammation.
    本发明涉及抑制PDE1A的化合物,PDE1A是一种磷酸二酯酶,参与调节软骨降解、关节退化以及涉及这种降解和/或炎症的疾病。
  • COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO
    申请人:UNIVERSITY OF IOWA RESEARCH FOUNDATION
    公开号:US20160115136A1
    公开(公告)日:2016-04-28
    Disclosed herein are compounds, such as benzimidazole derivatives, and composition, such as pharmaceutical compositions, and methods related thereto for treating or preventing microbial infections. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
  • [EN] NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES<br/>[FR] NOUVEAUX COMPOSÉS UTILISÉS DANS LE TRAITEMENT DE MALADIES DÉGÉNÉRATIVES ET INFLAMMATOIRES
    申请人:GALAPAGOS NV
    公开号:WO2008055959A1
    公开(公告)日:2008-05-15
    [EN] The present invention relates to compounds of formula (I) that are inhibitors of PDElA, a phosphodiesterase that is involved in the modulation of the degradation of cartilage, joint degeneration and diseases involving such degradation and/or inflammation.
    [FR] La présente invention concerne des composés représentés par la formule (I), qui sont des inhibiteurs de PDElA, une phosphodiestérase associée à la modulation de la dégradation du cartilage, la dégénération des articulations et les maladies associées à une telle dégradation et/ou inflammation.
  • [EN] COMPOUNDS, COMPOSITIONS COMPRISING SAME, AND METHODS RELATED THERETO<br/>[FR] COMPOSÉS, COMPOSITIONS LES COMPRENANT ET PROCÉDÉS ASSOCIÉS
    申请人:UNIV IOWA RES FOUND
    公开号:WO2014160405A1
    公开(公告)日:2014-10-02
    Discloaed herein are compounds, such as benzimidazole derivatives, and composition, such as pharmaceutical compoistions, and methods related thereto for treating or preventing microbial infections. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
查看更多